SCHEMBL2320835

SCHEMBL2320835

O=CNc1ccc(-c2cccc(Cl)c2)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 2/20 0.44
EGFR P00533 1/20 0.44
IGF1R P08069 1/20 0.44
MET P08581 1/20 0.44
PDGFRB P09619 1/20 0.44
KIT P10721 1/20 0.44
FGFR1 P11362 1/20 0.44
BRAF P15056 1/20 0.44
FGFR4 P22455 1/20 0.44
FLT4 P35916 1/20 0.44
KDR P35968 1/20 0.44
EPHB4 P54760 1/20 0.44
TEK Q02763 1/20 0.44
CNR2 P34972 1/20 0.44
EGLN1 Q9GZT9 2/20 0.43
PIM1 P11309 1/20 0.41
ALOX5 P09917 1/20 0.40
MAP4K4 O95819 5/20 0.40
TET3 O43151 1/20 0.40
BBOX1 O75936 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2327132 0.83 WNT3A (0.47) TEKEGLN1MAP4K4MEN1KMT2A
SCHEMBL2320060 0.82 DEGS1 (0.45) FLT1EGFRIGF1RMETPDGFRB
SCHEMBL212774 0.80 ACHE (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL11162903 0.80 CNR2 (0.47) FLT1EGFRIGF1RMETPDGFRB
SCHEMBL2320830 0.79 CNR2 (0.44) FLT1EGFRIGF1RMETPDGFRB
SCHEMBL20051805 0.78 USP30 (0.47) FLT1EGLN1PIM1ALOX5MAP4K4
SCHEMBL2324964 0.78 EPHB4 (0.48) KDREPHB4TEKMEN1KMT2A
SCHEMBL5247452 0.76 CNR2 (0.47) CNR2EGLN1ALOX5MAP4K4TAAR1
SCHEMBL30679648 0.76 CNR2 (0.47) CNR2EGLN1ALOX5MAP4K4TAAR1
SCHEMBL183711 0.75 L3MBTL1 (0.55) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094890-A1 PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS ARGUSINA INC. (US) 2011-08-11 WO disclosed